Sectra becomes 100% owner of Mamea Imaging AB

Sectra becomes 100% owner of Mamea Imaging AB The Swedish IT and medical-technology company Sectra AB has acquired 5,260 shares in Mamea Imaging AB from Life Equity Sweden KB, thereby increasing its ownership holding in the company from 95% to 100%. The acquisition has no material effect on Sectra's earnings and financial position. "As a result of the acquisition, we have completed the alignment of the ownership structure in Mamea Imaging AB," says Jan-Olof Brüer, CEO and President of Sectra AB. "The acquisition of Mamea is part of our increased focus on the mammography market, where our aim is to become established as a leading player with our unique mammography screening system, Sectra MicroDose Mammography." "This deal is industrially motivated and we are very satisfied with Sectra acquiring our share in Mamea. We look forward to a continued fast development and commercialization in this area", says Peter Zakrisson, Partner in Life Equity Sweden. The intention is to pay for the acquisition with Sectra shares on the same terms as when Sectra acquired a share majority in Mamea on April 30 from the company's founders. As payment for the acquisition, the Board of Directors has decided to carry out an issue of 47,387 B shares to the sellers based on the authorization the Board was granted at the Annual General Meeting in June 2003. The new issue corresponds to 0.1% of the share capital and 0.1% of the votes in the company. After the issue, Sectra's share capital amounts to SEK 36,439,438. Mamea Imaging AB was founded in 1999 by a research group at the Royal Institute of Technology in Stockholm and Sectra. The company has developed an entirely new type of digital radiology detector that combines high image quality with minimal radiation dosage. For further information, please contact: Sectra AB, Dr. Jan-Olof Brüer, President and CEO, +46 13 23 52 09, Visit Sectras website About Sectra Sectra has its roots in Linköping Institute of Technology and is one of Sweden's fastest growing high-tech companies in IT. Since the mid-1980s, Sectra has successfully conducted development and sales of advanced medical IT and telecommunications products. Today, the business includes products in medical systems and secure communication systems. Business is conducted in eight countries with a total of 347 employees. Sales for fiscal year 2003/2004 amounted to SEK 495 million. Since March 1999, Sectra's shares have been quoted on the O list of the Stockholm Exchange. About Life Equity Sweden Gatenbeck, Zakrisson Group is the exclusive advisor to H&B Capital LP and Life Equity Sweden KB. H&B Capital LP is a 95 M Euro private equity fund with focus on small and mid-sized growth companies in the Nordic region. The fund has a sector focus on biotech, med tech, health care IT, functional foods and consumer goods and services. Investors are primarily institutions as Skandia, The 6th Swedish National pension fund, Orkla, Alecta, LRF and Pharmacia. It was established in December 1999. Life Equity Sweden KB is a 65 M Euro private equity fund with focus on Swedish small and mid-sized life science companies. Skandia Liv is the sole investor. It was established in December 2002. The two funds have holdings in 20 portfolio companies. ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: press release pdf version

About Us

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2017/2018 fiscal year totaled SEK 1,267 million. The Sectra share (STO: SECT B) is quoted on the Nasdaq Stockholm exchange. For more information, visit


Documents & Links